Skip to main content

Table 6 Characteristics of patients who developed AKI during follow-up (n = 4944)

From: Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study

 

Metformin exposed AKI event

AKI event without concurrent metformin exposure

(n = 1972)

(n = 2972)

Age (Years) a

73.6 (65.7 – 79.4)

77.6 (70.4-83.7)

Male Sex (%)

1161 (58.9)

1533 (51.6)

HbA1c %

7.2 (6.5- 8.3)

6.8 (6.2- 7.9)

(mmol/mol) a

55 (48- 67)

51 (44- 63)

Diabetes Duration (years) a

9.15 (5.11- 13.85)

7.50 (3.30-13.76)

Number of diabetes drug classes (%)

0

13 (0.7)

1745 (58.7)

1

830 (42.1)

1049 (35.3)

2

897 (45.5)

162 (5.5)

3

212 (10.8)

16 (0.5)

4

19 (1.0)

0 (0.0)

5

1 (0.1)

0 (0.0)

CKD category (%)

>60

941 (47.7)

986 (33.2)

30-59

896 (45.4)

1476 (49.37)

<29 ml/min/1.732

130 (6.6)

492 (16.6)

  1. aMedian & IQR